How well is your organization prepared to pass an FDA audit?
On Oct. 25, 2022, presenters Sam Klooster, VP of Sales, SIMCO Electronics, and Jerry Chapman, Senior GMP Quality Expert, Redica Systems, shared insights and trends from the last five years on the top reasons regulated manufacturers receive 483 observations and warning letters in the webinar, “The Insider’s Guide to FDA Audit Readiness.”
Do not miss this opportunity to learn firsthand the data intelligence behind the five key factors that can impact your company’s FDA compliance, including:
- Audit Trails
- Digital/Electronic Signatures
- Access and Control
- Compliance and Validation
About the Experts
Jerry Chapman is a Senior GMP Quality Expert at Redica Systems. He writes the Redica Systems column “Conference Spotlight” and is working with our data engineers to build machine learning models for analysis of agency enforcement documents. He brings 40 years’ experience in the pharma industry, including 31 years at Eli Lilly in technical and leadership positions in research and product development, manufacturing, plant quality, site quality, corporate quality, and quality systems.
Sam Klooster brings over 15 years of experience in executive leadership, engineering and business development in both Fortune 500 companies and startups to his role as Vice President of SIMCO’s CERDAAC software business. Currently, he leads the development of CERDAAC’s software business strategy, managing the sales, marketing, operations, customers success and product teams to drive innovation and growth.
Subscribe to Redica Insights
Get quality and compliance insights from our experts in your inbox